Homocysteine trials--clear outcomes for complex reasons.

In 1969, McCully first proposed that homocysteine causes atherosclerosis.1 His hypothesis was based on the finding of atherosclerotic plaque at autopsies of young people with homocystinuria. This hypothesis was later modified to include a broader population, positing that mild hyperhomocysteinemia caused by dietary deficiencies of the vitamin cofactors required for the metabolism of homocysteine — folic acid, vitamin B12, and vitamin B6 — is a risk factor for atherothrombosis. In developed countries, these vitamins are partially removed from foods during processing,2 and typical diets are rich in the precursor amino acid methionine (which is derived from animal . . .

[1]  L. Chambless,et al.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. , 2004, JAMA.

[2]  Jonathan Goodfellow,et al.  Folic Acid Improves Endothelial Function in Coronary Artery Disease via Mechanisms Largely Independent of Homocysteine Lowering , 2002, Circulation.

[3]  Esteban Ballestar,et al.  DNA Methylation Polymorphisms Precede Any Histological Sign of Atherosclerosis in Mice Lacking Apolipoprotein E* , 2004, Journal of Biological Chemistry.

[4]  K. Woo,et al.  Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. , 2002, The American journal of medicine.

[5]  P. Jacques,et al.  Power Shortage: Clinical Trials Testing the Homocysteine Hypothesis against a Background of Folic AcidFortified Cereal Grain Flour , 2001, Annals of Internal Medicine.

[6]  H. Suryapranata,et al.  Folate Therapy and In-Stent Restenosis after Coronary Stenting , 2004 .

[7]  E. Falk,et al.  Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice. , 2003, Atherosclerosis.

[8]  L. Meyn,et al.  Procedures for pelvic organ prolapse in the United States, 1979-1997. , 2003, American journal of obstetrics and gynecology.

[9]  I. Mcdowell,et al.  Treatment of coronary heart disease with folic acid: is there a future? , 2004, American journal of physiology. Heart and circulatory physiology.

[10]  Per Magne Ueland,et al.  Homocysteine lowering and cardiovascular events after acute myocardial infarction. , 2006, The New England journal of medicine.

[11]  J. Loscalzo,et al.  Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. , 2000, The Journal of clinical investigation.

[12]  J. Loscalzo.  Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[13]  Per Magne Ueland,et al.  Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. , 2002, JAMA.

[14]  S. Yusuf,et al.  Homocysteine lowering with folic acid and B vitamins in vascular disease. , 2006, The New England journal of medicine.

[15]  G. Lund,et al.  Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia? , 2005, The Journal of nutrition.

[16]  R. Rozen,et al.  Effect of Mthfr genotype on diet-induced hyperhomocysteinemia and vascular function in mice. , 2004, Blood.

[17]  E. Vittinghoff,et al.  Cost of Pelvic Organ Prolapse Surgery in the United States , 2001, Obstetrics and gynecology.

[18]  K. Mccully.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. , 1969, The American journal of pathology.

[19]  D. Heistad,et al.  Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[20]  C. Bradley,et al.  Vaginal Wall Descensus and Pelvic Floor Symptoms in Older Women , 2005, Obstetrics and gynecology.

[21]  H. Schroeder.  Losses of vitamins and trace minerals resulting from processing and preservation of foods. , 1971, The American journal of clinical nutrition.

[22]  D. Grimes,et al.  Technology follies. The uncritical acceptance of medical innovation. , 1993, JAMA.

[23]  H. Suryapranata,et al.  Folate therapy and in-stent restenosis after coronary stenting. , 2004, The New England journal of medicine.

[24]  D. Wald,et al.  Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis , 2002, BMJ : British Medical Journal.